A Koneti Rao1, Robert J Freishtat2, Gauthami Jalagadugula3, Anamika Singh3, Guangfen Mao3, Andrew Wiles2, Peter Cheung4, Guenther Boden5. 1. Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, PA, USA; Department of Medicine, Temple University School of Medicine, Philadelphia, PA, USA. Electronic address: koneti@temple.edu. 2. Division of Emergency Medicine, Children's National Medical Center, Washington, DC, USA. 3. Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, PA, USA. 4. General Clinical Research Center, Temple University School of Medicine, Philadelphia, PA, USA. 5. Department of Medicine, Temple University School of Medicine, Philadelphia, PA, USA; General Clinical Research Center, Temple University School of Medicine, Philadelphia, PA, USA.
Abstract
INTRODUCTION: Diabetes mellitus (DM) is a prothrombotic and proinflammatory state. Hyperglycemia (HG) is encountered even in patients without DM. We have shown that combined HG and hyperinsulinemia (HI) in healthy non-diabetic subjects increased circulating tissue factor (TF) and thrombin generation. To understand the changes in platelet and monocyte pathways induced by combined HG and HI in healthy non-diabetic state, we performed whole genome expression profiling of leukocyte-depleted platelets and monocytes before and after 24 hours of combined HG (glucose ~200mg/dL) and HI by glucose infusion clamp in a healthy non-diabetic subject. RESULTS: We defined time-dependent differential mRNA expression (24 versus 0 hour fold change (FC) ≥ 2) common to platelets and monocytes. Ingenuity Pathways Analysis revealed alterations in canonical insulin receptor signaling and coagulation pathways. A preliminary group of 9 differentially expressed genes was selected for qRT-PCR confirmation. Platelet 24 hour sample was compared to the 0 hour sample plus 4 controls. Five transcripts in platelets and 6 in monocytes were confirmed. Platelet GSK3B and PTPN1 were upregulated, and STXBP4 was downregulated in insulin signaling, and F3 and TFPI were upregulated in coagulation pathways. Monocyte, PIK3C3, PTPN11 and TFPI were downregulated. Platelet GSKβ3 and PTPN11 protein and TF antigen in platelets and monocytes was increased. CONCLUSIONS: Even in non-diabetic state, HG+HI for 24 hours induces changes in platelets and monocytes. They suggest downregulation of insulin signaling and upregulation of TF. Further studies are needed to elucidate cellular alterations leading to the prothrombotic and proinflammatory state in DM.
INTRODUCTION:Diabetes mellitus (DM) is a prothrombotic and proinflammatory state. Hyperglycemia (HG) is encountered even in patients without DM. We have shown that combined HG and hyperinsulinemia (HI) in healthy non-diabetic subjects increased circulating tissue factor (TF) and thrombin generation. To understand the changes in platelet and monocyte pathways induced by combined HG and HI in healthy non-diabetic state, we performed whole genome expression profiling of leukocyte-depleted platelets and monocytes before and after 24 hours of combined HG (glucose ~200mg/dL) and HI by glucose infusion clamp in a healthy non-diabetic subject. RESULTS: We defined time-dependent differential mRNA expression (24 versus 0 hour fold change (FC) ≥ 2) common to platelets and monocytes. Ingenuity Pathways Analysis revealed alterations in canonical insulin receptor signaling and coagulation pathways. A preliminary group of 9 differentially expressed genes was selected for qRT-PCR confirmation. Platelet 24 hour sample was compared to the 0 hour sample plus 4 controls. Five transcripts in platelets and 6 in monocytes were confirmed. Platelet GSK3B and PTPN1 were upregulated, and STXBP4 was downregulated in insulin signaling, and F3 and TFPI were upregulated in coagulation pathways. Monocyte, PIK3C3, PTPN11 and TFPI were downregulated. Platelet GSKβ3 and PTPN11 protein and TF antigen in platelets and monocytes was increased. CONCLUSIONS: Even in non-diabetic state, HG+HI for 24 hours induces changes in platelets and monocytes. They suggest downregulation of insulin signaling and upregulation of TF. Further studies are needed to elucidate cellular alterations leading to the prothrombotic and proinflammatory state in DM.
Authors: N S Key; A Slungaard; L Dandelet; S C Nelson; C Moertel; L A Styles; F A Kuypers; R R Bach Journal: Blood Date: 1998-06-01 Impact factor: 22.113
Authors: J Min; S Okada; M Kanzaki; J S Elmendorf; K J Coker; B P Ceresa; L J Syu; Y Noda; A R Saltiel; J E Pessin Journal: Mol Cell Date: 1999-06 Impact factor: 17.970
Authors: M T Rondina; H Schwertz; E S Harris; B F Kraemer; R A Campbell; N Mackman; C K Grissom; A S Weyrich; G A Zimmerman Journal: J Thromb Haemost Date: 2011-04 Impact factor: 5.824
Authors: Alexandra Mazharian; Jun Mori; Ying-Jie Wang; Silke Heising; Benjamin G Neel; Steve P Watson; Yotis A Senis Journal: Blood Date: 2013-03-18 Impact factor: 22.113
Authors: Rehana Perveen; Kevin Funk; Jean Thuma; Shelli Wulf Ridge; Yanyan Cao; Jan Willem N Akkerman; Xiaozhuo Chen; Huzoor Akbar Journal: PLoS One Date: 2011-11-02 Impact factor: 3.752
Authors: Juan Pedro-Botet; Juan F Ascaso; Vivencio Barrios; Alejandro De la Sierra; Javier Escalada; Jesús Millán; Jose M Mostaza; Pablo Pérez-Martínez; Xavier Pintó; Jordi Salas-Salvadó; Pedro Valdivielso Journal: Diabetes Metab Syndr Obes Date: 2018-10-31 Impact factor: 3.168